NEW YORK, July 11, 2014 /PRNewswire/ -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Arizona on behalf of investors who purchased INSYS Therapeutics, Inc. ("INSYS" or the "Company") (Nasdaq: INSY) securities between May 1, 2013 and May 8, 2014.
For more information, click here: http://zlkdocs.com/INSY-Info-Request-Form-1970.
The complaint alleges that the Company made false and/or misleading statements and/or failed to disclose that: (a) the Company had engaged in illegal and/or unethical off-label marketing of its drug Subsys; (b) the Company was exposed to potential fines and other disciplinary actions as a result of said marketing practices; and (c) as a result, the Company's financial statements were materially false and misleading at all relevant times.
If you suffered a loss in INSYS you have until July 14, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlkdocs.com/INSY-Info-Request-Form-1970.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (866) 367-6510 www.zlk.com
SOURCE Levi & Korsinsky, LLP